ArticleFrontiers in immunology2025
C-reactive protein flare: a promising prognostic predictor for patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and immune checkpoint inhibitors.
Xinge Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.